BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Fish and Richardson

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,055,652

« Back to Dashboard

Summary for Patent: 4,055,652

Title: 1-[.beta.(R-thio)phenethyl]imidazoles and derivatives thereof
Abstract:Novel 1-[.beta.-(R-thio)phenethyl]-imidazoles and the corresponding 1-[.beta.-(R-sulfinyl)phenethyl]imidazoles and 1-[.beta.-(R-sulfonyl)phenethyl]imidazoles wherein R is alkyl, alkenyl, aralkenyl, substituted aralkenyl, alkynyl, cycloalkyl, cycloalkyl alkyl, aralkyl, substituted aralkyl, aryl or substituted aryl; and the antimicrobial acid addition salts thereof, are useful as antifungal, anti-bacterial and anti-protozoal agents.
Inventor(s): Walker; Keith A. M. (Palo Alto, CA)
Assignee: Syntex (U.S.A.) Inc. (Palo Alto, CA)
Application Number:05/664,453
Patent Claim Types:
see list of patent claims
Compound; Use; Composition; Dosage form; Delivery;

No matches for this query

International Patent Family for Patent: 4,055,652

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina224222► Subscribe
Austria347449► Subscribe
AustriaA727675► Subscribe
Australia496881► Subscribe
Australia8408175► Subscribe
Belgium833614► Subscribe
Canada1064040► Subscribe
Switzerland623813► Subscribe
Germany2541833► Subscribe
Denmark155283► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: